About Parallel Bio
Parallel Bio is a company based in Cambridge (United States) founded in 2020.. Parallel Bio has raised $25.43 million across 3 funding rounds from investors including Refactor Capital, Y Combinator and AIX Ventures. The company has 6 employees as of December 31, 2022. Parallel Bio offers products and services including Immune Organoids Platform and AI Drug Discovery Service. Parallel Bio operates in a competitive market with competitors including Newcells Biotech, InSphero, Pandorum, Vivodyne and Adapsyn, among others.
- Headquarter Cambridge, United States
- Employees 6 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Parallel Biosystems Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$25.43 M (USD)
in 3 rounds
-
Latest Funding Round
$21 M (USD), Series A
Jun 12, 2025
-
Investors
Refactor Capital
& 8 more
-
Employee Count
6
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Parallel Bio
Parallel Bio offers a comprehensive portfolio of products and services, including Immune Organoids Platform and AI Drug Discovery Service. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables in-vitro testing of drugs using human immune replicas.
Uses AI to analyze immune data for faster drug candidate verification.
Unlock access to complete
Funding Insights of Parallel Bio
Parallel Bio has successfully raised a total of $25.43M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $21 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $21.0M
-
First Round
First Round
(01 Jun 2021)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2025 | Amount | Series A - Parallel Bio | Valuation | AIX Ventures | |
| Jan, 2023 | Amount | Seed - Parallel Bio | Valuation | Refactor Capital |
|
| Jun, 2021 | Amount | Seed - Parallel Bio | Valuation | Y Combinator |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Parallel Bio
Parallel Bio has secured backing from 9 investors, including venture fund and angel investors. Prominent investors backing the company include Refactor Capital, Y Combinator and AIX Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early-stage investments are made across US and India.
|
Founded Year | Domain | Location | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location | |
|
Venture capital is provided to AI-powered companies by AIX Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Parallel Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Parallel Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Parallel Bio Comparisons
Competitors of Parallel Bio
Parallel Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Newcells Biotech, InSphero, Pandorum, Vivodyne and Adapsyn, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Induced pluripotent stem cell-derived organoid models are developed for research.
|
|
| domain | founded_year | HQ Location |
Cell-based assays and 3D microtissues for drug screening are developed.
|
|
| domain | founded_year | HQ Location |
Regenerative medicine and 3D tissues are developed for therapeutic uses.
|
|
| domain | founded_year | HQ Location |
Developer of AI-based platform for lab-grown human tissues
|
|
| domain | founded_year | HQ Location |
Provider of computational tools for bacterial metabolomic and genomic data analysis
|
|
| domain | founded_year | HQ Location |
Scalable processes for organoid expansion are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Parallel Bio
Frequently Asked Questions about Parallel Bio
When was Parallel Bio founded?
Parallel Bio was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is Parallel Bio located?
Parallel Bio is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Parallel Bio a funded company?
Parallel Bio is a funded company, having raised a total of $25.43M across 3 funding rounds to date. The company's 1st funding round was a Seed of $125K, raised on Jun 01, 2021.
How many employees does Parallel Bio have?
As of Dec 31, 2022, the latest employee count at Parallel Bio is 6.
What does Parallel Bio do?
Parallel Bio was founded in 2020 and is located in Cambridge, United States. The companys domain, parallel.bio, serves as its primary online identifier. Limited details are available concerning its industry sector, specific operations, or services provided. Further information on core activities remains undisclosed in public sources at this time.
Who are the top competitors of Parallel Bio?
Parallel Bio's top competitors include Newcells Biotech, InSphero and Vivodyne.
What products or services does Parallel Bio offer?
Parallel Bio offers Immune Organoids Platform and AI Drug Discovery Service.
Who are Parallel Bio's investors?
Parallel Bio has 9 investors. Key investors include Refactor Capital, Y Combinator, AIX Ventures, Marc Benioff, and Metaplanet.